159 related articles for article (PubMed ID: 16719371)
1. Establishment of functional human cytochrome P450 monooxygenase systems in Escherichia coli.
Pritchard MP; McLaughlin L; Friedberg T
Methods Mol Biol; 2006; 320():19-29. PubMed ID: 16719371
[TBL] [Abstract][Full Text] [Related]
2. Coexpression of mammalian cytochrome P450 and reductase in Escherichia coli.
Dong J; Porter TD
Arch Biochem Biophys; 1996 Mar; 327(2):254-9. PubMed ID: 8619611
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of Escherichia coli membrane preparations of canine CYP1A1, 2B11, 2C21, 2C41, 2D15, 3A12, and 3A26 with coexpressed canine cytochrome P450 reductase.
Locuson CW; Ethell BT; Voice M; Lee D; Feenstra KL
Drug Metab Dispos; 2009 Mar; 37(3):457-61. PubMed ID: 19074522
[TBL] [Abstract][Full Text] [Related]
4. Establishment of a novel host, high-red yeast that stably expresses hamster NADPH-cytochrome P450 oxidoreductase: usefulness for examination of the function of mammalian cytochrome P450.
Ohgiya S; Goda T; Hoshino T; Kamataki T; Ishizaki K
Arch Biochem Biophys; 1997 Jul; 343(2):215-24. PubMed ID: 9224733
[TBL] [Abstract][Full Text] [Related]
5. Expression of modified human cytochrome P450 3A4 in Escherichia coli and purification and reconstitution of the enzyme.
Gillam EM; Baba T; Kim BR; Ohmori S; Guengerich FP
Arch Biochem Biophys; 1993 Aug; 305(1):123-31. PubMed ID: 8342945
[TBL] [Abstract][Full Text] [Related]
6. Subcellular localization, aggregation state, and catalytic activity of microsomal P450 cytochromes modified in the NH2-terminal region and expressed in Escherichia coli.
Pernecky SJ; Olken NM; Bestervelt LL; Coon MJ
Arch Biochem Biophys; 1995 Apr; 318(2):446-56. PubMed ID: 7733676
[TBL] [Abstract][Full Text] [Related]
7. Molecular cloning, expression and characterization of an endogenous human cytochrome P450 arachidonic acid epoxygenase isoform.
Zeldin DC; DuBois RN; Falck JR; Capdevila JH
Arch Biochem Biophys; 1995 Sep; 322(1):76-86. PubMed ID: 7574697
[TBL] [Abstract][Full Text] [Related]
8. Expression of cytochrome P450 3A7 in Escherichia coli: effects of 5' modification and catalytic characterization of recombinant enzyme expressed in bicistronic format with NADPH-cytochrome P450 reductase.
Gillam EM; Wunsch RM; Ueng YF; Shimada T; Reilly PE; Kamataki T; Guengerich FP
Arch Biochem Biophys; 1997 Oct; 346(1):81-90. PubMed ID: 9328287
[TBL] [Abstract][Full Text] [Related]
9. Recombinant human cytochrome P450 1A2 and an N-terminal-truncated form: construction, purification, aggregation properties, and interactions with flavodoxin, ferredoxin, and NADPH-cytochrome P450 reductase.
Dong MS; Yamazaki H; Guo Z; Guengerich FP
Arch Biochem Biophys; 1996 Mar; 327(1):11-9. PubMed ID: 8615680
[TBL] [Abstract][Full Text] [Related]
10. Autodisplay of functional CYP106A2 in Escherichia coli.
Schumacher SD; Hannemann F; Teese MG; Bernhardt R; Jose J
J Biotechnol; 2012 Oct; 161(2):104-12. PubMed ID: 22426093
[TBL] [Abstract][Full Text] [Related]
11. Molecular, enzymatic, and regulatory characterization of rat kidney cytochromes P450 4A2 and 4A3.
Helvig C; Dishman E; Capdevila JH
Biochemistry; 1998 Sep; 37(36):12546-58. PubMed ID: 9730827
[TBL] [Abstract][Full Text] [Related]
12. Optimizations to achieve high-level expression of cytochrome P450 proteins using Escherichia coli expression systems.
Zelasko S; Palaria A; Das A
Protein Expr Purif; 2013 Nov; 92(1):77-87. PubMed ID: 23973802
[TBL] [Abstract][Full Text] [Related]
13. A model for human cytochrome P450 2D6 based on homology modeling and NMR studies of substrate binding.
Modi S; Paine MJ; Sutcliffe MJ; Lian LY; Primrose WU; Wolf CR; Roberts GC
Biochemistry; 1996 Apr; 35(14):4540-50. PubMed ID: 8605204
[TBL] [Abstract][Full Text] [Related]
14. High-level heterologous expression of fungal cytochrome P450s in Escherichia coli.
Ichinose H; Wariishi H
Biochem Biophys Res Commun; 2013 Aug; 438(2):289-94. PubMed ID: 23886957
[TBL] [Abstract][Full Text] [Related]
15. Purification and characterization of recombinant-expressed cytochrome P450 2C3 from Escherichia coli: 2C3 encodes the 6 beta-hydroxylase deficient form of P450 3b.
Richardson TH; Hsu MH; Kronbach T; Barnes HJ; Chan G; Waterman MR; Kemper B; Johnson EF
Arch Biochem Biophys; 1993 Jan; 300(1):510-6. PubMed ID: 8380971
[TBL] [Abstract][Full Text] [Related]
16. Structural determination of the substrate specificities and regioselectivities of the rat and human fatty acid omega-hydroxylases.
Hoch U; Zhang Z; Kroetz DL; Ortiz de Montellano PR
Arch Biochem Biophys; 2000 Jan; 373(1):63-71. PubMed ID: 10620324
[TBL] [Abstract][Full Text] [Related]
17. Formation of indigo by recombinant mammalian cytochrome P450.
Gillam EM; Aguinaldo AM; Notley LM; Kim D; Mundkowski RG; Volkov AA; Arnold FH; Soucek P; DeVoss JJ; Guengerich FP
Biochem Biophys Res Commun; 1999 Nov; 265(2):469-72. PubMed ID: 10558891
[TBL] [Abstract][Full Text] [Related]
18. Expression of modified cytochrome P450 2C10 (2C9) in Escherichia coli, purification, and reconstitution of catalytic activity.
Sandhu P; Baba T; Guengerich FP
Arch Biochem Biophys; 1993 Nov; 306(2):443-50. PubMed ID: 8215449
[TBL] [Abstract][Full Text] [Related]
19. Construction of a human cytochrome P450 1A1: rat NADPH-cytochrome P450 reductase fusion protein cDNA and expression in Escherichia coli, purification, and catalytic properties of the enzyme in bacterial cells and after purification.
Chun YJ; Shimada T; Guengerich FP
Arch Biochem Biophys; 1996 Jun; 330(1):48-58. PubMed ID: 8651703
[TBL] [Abstract][Full Text] [Related]
20. Extending the diversity of cytochrome P450 enzymes by DNA family shuffling.
Rosic NN; Huang W; Johnston WA; DeVoss JJ; Gillam EM
Gene; 2007 Jun; 395(1-2):40-8. PubMed ID: 17400405
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
